• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钒酸盐与人血清转铁蛋白的结合。

Binding of vanadate to human serum transferrin.

作者信息

Harris W R, Carrano C J

出版信息

J Inorg Biochem. 1984 Nov;22(3):201-18. doi: 10.1016/0162-0134(84)80029-x.

DOI:10.1016/0162-0134(84)80029-x
PMID:6569067
Abstract

Human serum transferrin specifically and reversibly binds 2 equiv of vanadate at the two metal-binding sites of the protein. The vanadium(V)-transferrin complex can be formed either by the addition of vanadate to apotransferrin or by the air oxidation of the vanadyl(IV)-transferrin complex. The formation of the vanadium complex can be blocked by loading the apotransferrin with iron(III), and bound vanadium can be displaced from the protein by the subsequent addition of either gallium(III) or iron(III). The binding constant for the second equiv of vanadate is 10(6.5) in 0.1 M hepes, pH 7.4 at 25 degrees C. The binding constant for the first equiv of vanadate is probably very similar, although no quantitative value could be determined. Although transferrin reacts with the vanadate anion, studies on the transferrin model compound ethylenebis(o-hydroxyphenylglycine) indicate that at pH 9.5, the vanadium is binding at the metal-binding site as a dioxovanadium(V) cation coordinated to two phenolic residues at each binding site. This bound cation appears to be protonated over the pH range 9.5-6.5, as shown by changes in the difference uv spectrum of the transferrin complex, to produce an oxohydroxo species. Further decreases in the pH lead to dissociation of the vanadium-transferrin complex.

摘要

人血清转铁蛋白在该蛋白质的两个金属结合位点特异性且可逆地结合2当量的钒酸盐。钒(V)-转铁蛋白复合物既可以通过向脱铁转铁蛋白中添加钒酸盐形成,也可以通过钒酰(IV)-转铁蛋白复合物的空气氧化形成。钒复合物的形成可以通过用铁(III)加载脱铁转铁蛋白来阻断,并且随后添加镓(III)或铁(III)可以将结合的钒从蛋白质中置换出来。在25℃下,0.1M HEPES,pH 7.4中,第二当量钒酸盐的结合常数为10(6.5)。尽管无法确定定量值,但第一当量钒酸盐的结合常数可能非常相似。虽然转铁蛋白与钒酸根阴离子反应,但对转铁蛋白模型化合物乙二双(邻羟基苯甘氨酸)的研究表明,在pH 9.5时,钒在金属结合位点以双氧钒(V)阳离子的形式结合,在每个结合位点与两个酚残基配位。如转铁蛋白复合物的差示紫外光谱变化所示,这种结合的阳离子在pH 9.5-6.5范围内似乎被质子化,以产生氧氢氧根物种。pH进一步降低导致钒-转铁蛋白复合物解离。

相似文献

1
Binding of vanadate to human serum transferrin.钒酸盐与人血清转铁蛋白的结合。
J Inorg Biochem. 1984 Nov;22(3):201-18. doi: 10.1016/0162-0134(84)80029-x.
2
Behavior of vanadate and vanadyl ion in canine blood.钒酸盐和氧钒离子在犬类血液中的行为。
J Inorg Biochem. 1984 Feb;20(2):157-69. doi: 10.1016/0162-0134(84)80015-x.
3
Thermodynamics of anion binding to human serum transferrin.阴离子与人类血清转铁蛋白结合的热力学
Biochemistry. 1985 Dec 3;24(25):7412-8. doi: 10.1021/bi00346a057.
4
Nonequivalence of the metal binding sites in vanadyl-labeled human serum transferrin.钒酰标记的人血清转铁蛋白中金属结合位点的不等效性。
Biochemistry. 1975 Oct 21;14(21):4573-7. doi: 10.1021/bi00692a003.
5
Vanadium complexes of transferrin and ferritin in the rat.大鼠体内转铁蛋白和铁蛋白的钒配合物
Biochim Biophys Acta. 1986 Oct 29;884(1):84-92. doi: 10.1016/0304-4165(86)90230-8.
6
Cofactor and substrate binding to vanadium chloroperoxidase determined by UV-VIS spectroscopy and evidence for high affinity for pervanadate.通过紫外可见光谱法测定辅因子和底物与钒氯过氧化物酶的结合以及对过氧钒酸盐具有高亲和力的证据。
Biochemistry. 2000 Feb 8;39(5):1133-41. doi: 10.1021/bi9921790.
7
Electron paramagnetic resonance and difference ultraviolet studies of Mn2+ binding to serum transferrin.锰离子与血清转铁蛋白结合的电子顺磁共振和差示紫外研究。
J Inorg Biochem. 1994 Apr;54(1):1-19. doi: 10.1016/0162-0134(94)85119-0.
8
Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.利用高效液相色谱/高分辨率电感耦合等离子体质谱研究健康人血清中钒与转铁蛋白的结合模式。
Analyst. 2004 Jan;129(1):51-4. doi: 10.1039/b311013n. Epub 2003 Nov 27.
9
Contrasting synergistic anion effects in vanadium(V) binding to nicatransferrin versus human serum transferrin.钒(V)与尼克酞基转移蛋白和人血清转铁蛋白结合的协同阴离子效应的对比。
Biochemistry. 2009 Dec 15;48(49):11609-11. doi: 10.1021/bi901630j.
10
Metal site conformational states of vanadyl(IV) human serotransferrin complexes.钒(IV)人血清转铁蛋白复合物的金属位点构象状态
Biochemistry. 1977 Feb 8;16(3):363-5. doi: 10.1021/bi00622a004.

引用本文的文献

1
Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.钒:综合其药理毒理机制和多方面应用的全面概述,以及对进一步研究趋势的总结,探讨其风险和可能的益处。
J Trace Elem Med Biol. 2020 Sep;61:126508. doi: 10.1016/j.jtemb.2020.126508. Epub 2020 Apr 12.
2
Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications.钒:历史、化学性质、与α-氨基酸的相互作用及潜在治疗应用
Coord Chem Rev. 2018 Oct 1;372:117-140. doi: 10.1016/j.ccr.2018.06.002. Epub 2018 Jun 21.
3
Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.
钒在生物作用中的作用:化学、药理学方面以及糖尿病中的代谢影响。
Biol Trace Elem Res. 2019 Mar;188(1):68-98. doi: 10.1007/s12011-018-1540-6. Epub 2018 Oct 22.
4
Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.转铁蛋白和柠檬酸盐在调控 Ti(IV)形态、传输和毒性方面的异常协同作用。
J Am Chem Soc. 2016 May 4;138(17):5659-65. doi: 10.1021/jacs.6b01966. Epub 2016 Apr 26.
5
Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.为何抗糖尿病钒配合物未纳入“大型制药公司”药物研发流程?批判性综述。
Curr Med Chem. 2016;23(25):2874-2891. doi: 10.2174/0929867323666160321121138.
6
The thermodynamics of protein interactions with essential first row transition metals.蛋白质与重要的第一排过渡金属相互作用的热力学
Biochim Biophys Acta. 2016 May;1860(5):879-891. doi: 10.1016/j.bbagen.2015.11.005. Epub 2015 Nov 10.
7
Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution.静脉注射含钒白蛋白溶液后钒在人体内的药代动力学。
Br J Clin Pharmacol. 2003 Mar;55(3):241-5. doi: 10.1046/j.1365-2125.2003.01711.x.